EMEA-000898-PIP01-10-M02 - paediatric investigation plan

Meropenem

Key facts

• Active substance:
  Meropenem
• Therapeutic area:
  Infectious diseases
• Decision number:
  P/0065/2016
• PIP number:
  EMEA-000898-PIP01-10-M02
• Pharmaceutical form(s):
  Powder for solution for injection or infusion
• Condition(s) / indication(s):
  • Treatment of bacterial meningitis
  • Treatment of bacterial sepsis
• Route(s) of administration:
  Intravenous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  18/03/2016
• Compliance check done:
  No

Decision

P/0065/2016: EMA decision of 18 March 2016 on the acceptance of a modification of an agreed paediatric investigation plan for meropenem (EMEA-000898-PIP01-10-M02)

Adopted Reference Number: EMA/131047/2016